Get started
Globus Medical, Inc.Globus Medical, Inc.Globus Medical, Inc.

Globus Medical, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

GMED chart


Full chart

GMED upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪11.38 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
127.35
Basic EPS (TTM)
0.67 USD
Net income (FY)
‪122.87 M‬ USD
Revenue (FY)
‪1.57 B‬ USD
Shares float
‪112.93 M‬
Beta (1Y)
0.66

Employees


Employees (FY)
‪5 K‬
Change (1Y)
‪+2.4 K‬ +92.31%
Revenue / Employee (1Y)
‪313.70 K‬ USD
Net income / Employee (1Y)
‪24.57 K‬ USD

About Globus Medical, Inc.


Sector
Health Technology
Industry
Medical Specialties
CEO
Daniel T. Scavilla
Website
globusmedical.com
Headquarters
Audubon
Founded
2003
FIGI
BBG002V87SD0
Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with musculoskeletal disorders. It classifies products into Innovative Fusion and Disruptive Technology. It operates through the United States and International geographical segments. The company was founded by David C. Paul, David D. Davidar and Andrew Iott in March 2003 and is headquartered in Audubon, PA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

GMED news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

GMED highest yielding bonds


N
NUVA5157058
NuVasive, Inc. 0.375% 15-MAR-2025
Yield to maturity
12.38%
Maturity date
Mar 15, 2025

Explore more bonds 

Frequently Asked Questions


The current price of GMED is 83.26 USD — it has decreased by −0.98% in the past 24 hours. Watch Globus Medical, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Globus Medical, Inc. stocks are traded under the ticker GMED.
GMED stock has risen by 0.21% compared to the previous week, the month change is a −3.18% fall, over the last year Globus Medical, Inc. has showed a 55.07% increase.
We've gathered analysts' opinions on Globus Medical, Inc. future price: according to them, GMED price has a max estimate of 115.00 USD and a min estimate of 80.00 USD. Watch GMED chart and read a more detailed Globus Medical, Inc. stock forecast: see what analysts think of Globus Medical, Inc. and suggest that you do with its stocks.
GMED reached its all-time high on Dec 2, 2024 with the price of 87.22 USD, and its all-time low was 10.26 USD and was reached on Dec 31, 2012. View more price dynamics on GMED chart.
See other stocks reaching their highest and lowest prices.
GMED stock is 1.54% volatile and has beta coefficient of 0.66. Track Globus Medical, Inc. stock price on the chart and check out the list of the most volatile stocks — is Globus Medical, Inc. there?
Today Globus Medical, Inc. has the market capitalization of ‪11.38 B‬, it has increased by 2.07% over the last week.
Yes, you can track Globus Medical, Inc. financials in yearly and quarterly reports right on TradingView.
Globus Medical, Inc. is going to release the next earnings report on Feb 20, 2025. Keep track of upcoming events with our Earnings Calendar.
GMED earnings for the last quarter are 0.83 USD per share, whereas the estimation was 0.65 USD resulting in a 28.26% surprise. The estimated earnings for the next quarter are 0.74 USD per share. See more details about Globus Medical, Inc. earnings.
Globus Medical, Inc. revenue for the last quarter amounts to ‪625.71 M‬ USD, despite the estimated figure of ‪604.69 M‬ USD. In the next quarter, revenue is expected to reach ‪635.43 M‬ USD.
GMED net income for the last quarter is ‪51.84 M‬ USD, while the quarter before that showed ‪31.76 M‬ USD of net income which accounts for 63.21% change. Track more Globus Medical, Inc. financial stats to get the full picture.
No, GMED doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 30, 2024, the company has ‪5.00 K‬ employees. See our rating of the largest employees — is Globus Medical, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Globus Medical, Inc. EBITDA is ‪438.16 M‬ USD, and current EBITDA margin is 22.10%. See more stats in Globus Medical, Inc. financial statements.
Like other stocks, GMED shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Globus Medical, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Globus Medical, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Globus Medical, Inc. stock shows the buy signal. See more of Globus Medical, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.